Vaccination of animals is an essential part of animal health
management. It helps to boost the immune system and keep animals safe from
various bacterial and viral infections. Autogenous vaccines are most preferred
for animal vaccination purposes. Federal guidelines state that an autogenous
vaccine is made from a bacterial or viral strain of the diseased animal.
Products made from these strains can only be marketed by veterinarian or farm
owners from where they were isolated.
Get Going With Sample Of Autogenous Vaccines
Market Report! https://www.persistencemarketresearch.com/samples/29491
Over the years, there has been growing demand for autogenous
vaccines that are derived from bacterial strains, owing to their greater
efficacy as compared to viral strains. Salmonella, Staphylococcus, Haemophilus,
and Mycoplasma are some of the commonly used bacterial strains to develop
autogenous bacterial vaccines. Growing prevalence of bacterial infections among
animals, preference toward autogenous vaccines over antibiotics, and increased
funding and support for international animal disease eradication are likely to
upswing demand for autogenous bacterial vaccines over the coming years.
According to a revised report published by Persistence Market
Research, the autogenous vaccines market was
valued over US$ 116 Mn in 2020, and is predicted to witness an impressive CAGR
of 5.5% over the forecast period (2021-2031).
Key Takeaways from
Market Study
- By
type of strain, bacterial autogenous vaccines are expected to contribute
to more than 1/3 revenue share in the market.
- By
end user, livestock farming companies will lead by acquiring over 45% of
market share. This sector has witnessed the most adoption of autogenous
vaccines as compared to other end users.
- Europe
holds around half of the global market share.
- Key
players are focused on expanding their product portfolios and expansion at
regional levels through collaborations and acquisitions.
- COVID-19
outbreak in big economies is expected to negatively impact demand for
autogenous vaccines owing to reduced healthcare center visits. Impact was
also observed on vaccine production and transportation owing to travel
restriction and lack of workforce at production centers.
- The
market in Thailand is projected to be the fastest-growing in the Asia
Pacific region, and will expand at a CAGR above 5% through 2031.
- The
U.S. market holds a big portion of revenue, and its market share accounts
for more than 90% in North America.
“Increasing preference for autogenous vaccines over antibiotics
will catalyze market growth over the coming years,” says an analyst of Persistence Market Research.
How About Re-Inventing The Methodical Wheel In
The Autogenous Vaccines Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.com/methodology/29491
Collaborations &
Acquisitions Key Strategies amongst Market Players
Prominent players manufacturing autogenous vaccines are
collectively increasing their product ranges through strategic initiatives such
as acquisitions and reaching out to emerging markets. Increasing investments
and manufacturing capacity expansion are expected to favour market growth over
the forecast period.
For instance,
- In
September 2019, Agri Labs (Huvepharma, Inc.) established a new
fermentation plant in Peshtera, Southern Bulgaria.
- In
May 2017, Elanco Animal Health opened a new manufacturing facility for
autogenous poultry vaccines in Winslow, Maine.
- Agreement
to acquire Bayer AG‘s animal health business by Elanco Animal Health in
August 2019 is one of the major acquisitions in this space. This strategic
move will help Elanco Animal Health enhance its market position.
What Does the Report
Cover?
Persistence Market Research offers a unique perspective and
actionable insights on the autogenous vaccines market in its latest study,
presenting historical demand assessment of 2016-2020 and projections for
2021-2031, on the basis of strain (bacterial strain and viral strain) and end
user (veterinary research institutes, livestock farming companies, and
veterinary clinics and hospitals), across the five key regions of the world.
Keeping A Tab On Key Players In The Autogenous
Vaccines Market? Go To “Purchase Now” To Decipher The Competitive Analysis In
Our Autogenous Vaccines Market Report! https://www.persistencemarketresearch.com/checkout/29491
About Us:
Persistence Market Research is here to
provide companies a one-stop solution with regards to bettering customer
experience. It does engage in gathering appropriate feedback after getting
through personalized customer interactions for adding value to customers’
experience by acting as the “missing” link between “customer relationships” and
“business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence
Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
Comments
Post a Comment